Monthly archive | PharmaTutor

2 October 2025

Novartis Require Regulatory Coordinator - Chemistry, Pharmacy, Biochemistry, Biotechnology Degree Apply

Contributes and support the development of submission of product registration, progress reports, supplements, amendments, and/or periodic experience reports.

2 October 2025

Openings for B.Pharm, M.Pharm as QA Associate Manager at Accenture

The person should require minimal guidance when determining methods and procedures on new assignments. Decisions often impact the team in which they reside and occasionally impact other teams.

2 October 2025

IQVIA looking for Clinical Data Management - B.Pharm Apply

Provide comprehensive data management expertise to Data Management team to provide high quality data management products that meet customer needs.

2 October 2025

Roche looking for Global Analytics Senior Analyst | B.Pharm, M.Pharm, Life Sciences Apply

Bachelors degree in Engineering (B.Tech/B.E.), Pharmacy (B.Pharma), Life Sciences, or a related discipline. A Masters degree such as M.Tech, M.Pharma, MBA, or equivalent is highly preferred

2 October 2025

Senior Associate Scientific Communications Require at Amgen

Doctorate degree in life sciences, pharmacy, biomedical sciences, or a related field

2 October 2025

Require Clinical Trial Coordinator at Thermo Fisher Scientific

Ensures allocated tasks are performed on time, within budget and to a high quality standard. Proactively communicates any risks to project leads and line manager as appropriate

2 October 2025

Novartis Hiring Senior QA Expert

Supplier qualification: Ensures a valid Quality Agreement in line with the requirements of the Novartis global template is in place and continuously amended to the business needs.

1 October 2025

AbbVie expands Biologics Manufacturing and R&D Presence in the U.S., invests USD 70 mn

AbbVie announced the start of construction of a USD 70 million expansion at its AbbVie Bioresearch Center (ABC) in Worcester, Mass., which serves as a center of excellence for biologics research and development and manufacturing. This expansion is part of the company's previously announced commitment to invest more than USD 10 billion of capital in the U.S. to broadly support innovation and expand critical biologics manufacturing capabilities and capacity.